세계의 개용 경구 츄어블 타블렛 시장 : 제품 유형, 용도, 포장별 예측(2025-2030년)

The Canine Oral Chewable Tablets Market was valued at USD 3.16 billion in 2023, expected to reach USD 3.30 billion in 2024, and is projected to grow at a CAGR of 5.42%, to USD 4.58 billion by 2030.

The market for Canine Oral Chewable Tablets predominantly revolves around pet healthcare, especially considering oral hygiene, anti-parasitic treatments, and dietary supplements for dogs. These products cater to improving digestive and oral health, controlling fleas and ticks, and delivering essential nutrients. The necessity for these tablets arises from increasing pet ownership, awareness regarding pet health, and a rising willingness among pet owners to invest in preventive healthcare. The end-use scope primarily encompasses veterinary clinics, pet stores, and online retail channels. Growth in this market is significantly influenced by the trend of humanization of pets, which drives demand for premium pet healthcare products. Increased R&D in the pet pharmaceutical industry, along with an upsurge in online retailing, signifies potential opportunities. Companies can consider expanding product lines to address specific health issues, such as probiotics for digestive health or joint care products as preventive measures for aging dogs. However, stringent regulations, coupled with a lack of awareness in developing regions, pose challenges. Price sensitivity among pet owners and competition from generic counterpart offerings further inhibit rapid market growth. Innovations in this industry could focus on enhancing product palatability and nutritional value, as well as eco-friendly packaging solutions. The development of personalized healthcare regimens using data analytics could offer competitive advantages. While the market landscape exhibits steady growth, the nature of the market remains competitive and fragmented, with major players investing extensively in marketing and product differentiation strategies. To address market limitations, strengthening distribution networks and educating consumers on the benefits of oral chewable tablets can widen reach and acceptance. The evolving consumer preferences provide an impetus for companies to innovate continuously and cater to a sophisticated and informed pet owner demographic.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Canine Oral Chewable Tablets Market

The Canine Oral Chewable Tablets Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing pet adoption rates leading to higher demand for canine oral healthcare products
  • Rising awareness among pet owners about the importance of canine dental hygiene
  • Innovations in veterinary pharmaceuticals enhancing the effectiveness and appeal of oral chewable tablets
  • Growing trend of premium pet products driven by humanization of pets
• Market Restraints
  • High research and development for developing effective and safe formulations for canine oral chewable tablets
  • High competition among the alternative products
• Market Opportunities
  • Expanding distribution networks to tap into untapped regions for canine oral chewable tablets
  • Customization of chewable tablets based on specific breeds' oral health needs in canine market
  • Collaborations with veterinary clinics to endorse canine oral chewable tablets for better health
• Market Challenges
  • Lack of awareness among the pet owners regarding the importance of oral health
  • Supply chain disruptions due to global logistics issues or availability of raw materials

Porter's Five Forces: A Strategic Tool for Navigating the Canine Oral Chewable Tablets Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Canine Oral Chewable Tablets Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Canine Oral Chewable Tablets Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Canine Oral Chewable Tablets Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Canine Oral Chewable Tablets Market

A detailed market share analysis in the Canine Oral Chewable Tablets Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Canine Oral Chewable Tablets Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Canine Oral Chewable Tablets Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Canine Oral Chewable Tablets Market

A strategic analysis of the Canine Oral Chewable Tablets Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Canine Oral Chewable Tablets Market, highlighting leading vendors and their innovative profiles. These include Bayer Animal Health, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Colgate-Palmolive Company, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Eli Lilly and Company, Hill's Pet Nutrition, Inc., Mars Petcare, Merck Animal Health, Nestle Purina PetCare, Nutramax Laboratories Veterinary Sciences, Inc., Phibro Animal Health Corporation, Royal Canin, Vetoquinol S.A., Virbac S.A., WellPet LLC, Zoetis Inc., and Zooplus AG.

Market Segmentation & Coverage

This research report categorizes the Canine Oral Chewable Tablets Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Non-Prescription Tablets and Prescription Tablets. The Non-Prescription Tablets is further studied across Natural Ingredients and Synthetic Ingredients.
• Based on Application, market is studied across Dental Treatment and Oral Health Maintenance. The Dental Treatment is further studied across Plaque Removal and Tartar Control. The Oral Health Maintenance is further studied across Daily Chewables and Occasional Chewables.
• Based on Packaging, market is studied across Bulk Containers, Multi-Pack Blister, and Single Pack.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing pet adoption rates leading to higher demand for canine oral healthcare products
    • 5.1.1.2. Rising awareness among pet owners about the importance of canine dental hygiene
    • 5.1.1.3. Innovations in veterinary pharmaceuticals enhancing the effectiveness and appeal of oral chewable tablets
    • 5.1.1.4. Growing trend of premium pet products driven by humanization of pets
  • 5.1.2. Restraints
    • 5.1.2.1. High research and development for developing effective and safe formulations for canine oral chewable tablets
    • 5.1.2.2. High competition among the alternative products
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding distribution networks to tap into untapped regions for canine oral chewable tablets
    • 5.1.3.2. Customization of chewable tablets based on specific breeds' oral health needs in canine market
    • 5.1.3.3. Collaborations with veterinary clinics to endorse canine oral chewable tablets for better health
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness among the pet owners regarding the importance of oral health
    • 5.1.4.2. Supply chain disruptions due to global logistics issues or availability of raw materials
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Canine Oral Chewable Tablets Market, by Product Type

• 6.1. Introduction
• 6.2. Non-Prescription Tablets
  • 6.2.1. Natural Ingredients
  • 6.2.2. Synthetic Ingredients
• 6.3. Prescription Tablets

7. Canine Oral Chewable Tablets Market, by Application

• 7.1. Introduction
• 7.2. Dental Treatment
  • 7.2.1. Plaque Removal
  • 7.2.2. Tartar Control
• 7.3. Oral Health Maintenance
  • 7.3.1. Daily Chewables
  • 7.3.2. Occasional Chewables

8. Canine Oral Chewable Tablets Market, by Packaging

• 8.1. Introduction
• 8.2. Bulk Containers
• 8.3. Multi-Pack Blister
• 8.4. Single Pack

9. Americas Canine Oral Chewable Tablets Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Canine Oral Chewable Tablets Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Canine Oral Chewable Tablets Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bayer Animal Health
• 2. Boehringer Ingelheim Animal Health
• 3. Ceva Sante Animale
• 4. Colgate-Palmolive Company
• 5. Dechra Pharmaceuticals PLC
• 6. Elanco Animal Health Incorporated
• 7. Eli Lilly and Company
• 8. Hill's Pet Nutrition, Inc.
• 9. Mars Petcare
• 10. Merck Animal Health
• 11. Nestle Purina PetCare
• 12. Nutramax Laboratories Veterinary Sciences, Inc.
• 13. Phibro Animal Health Corporation
• 14. Royal Canin
• 15. Vetoquinol S.A.
• 16. Virbac S.A.
• 17. WellPet LLC
• 18. Zoetis Inc.
• 19. Zooplus AG